Cancer development and spread (DONE) Flashcards
Historical context
Cancer known for many centuries- evidence from mummified remains, term cancer introduced by Hippocrates, relatively uncommon
Scientific advancement during 1800 and 1900s- better instrumentation to enhance understanding of cells and tissues
Early 1900s saw cancer emerging as medical diagnosis
Mid 1900s: advent of chemotherapy, cancer societies and significant government funding
Cancer statistics
Cases: 360,000 in UK, 50% of these are breast, prostate, lung and bowel
Deaths: 164,000 in UK, lung cancer accounts for more than 20% of these, over 50% of deaths are in people 75 years or older
Survival: 50% survive cancer for 10 or more years
Preventable cases: 38% of cases in UK are preventable
Cancers develop due to a build up of mutations in genes that control key cellular function
DNA damage (mutation) causes initiation Proliferation (growth promoters) leads to promotion Development of cancerous phenotype results in progression Mutations build up over time until a cancerous phenotype occurs
CRC adenoma-carcinoma sequence: Vogelstein’s model
Normal colon- APC, abnormalities
Hyperproliferative epithelium- methylation abnormalities
Adenoma- 18q deletion
Carcinoma- p53 deletion
Further accumulation of genetic abnormalities
Cancer hallmarks definition
Protein product of tumour suppressor genes inhibits cellular processes central to cancer hallmarks
Hallmarks: defining features of a cancer cell
Six cancer hallmarks
Self-sufficiency in growth signals Insensitivity to antigrowth signals Evading apoptosis Limitless replicative potential Sustained angiogenesis Tissue invasion and metastasis
Tumour suppressor genes
Protein product of tumour suppressor genes inhibits cellular process central to cancer hallmarks- mitosis, migration/invasion etc.
Tumour suppressor gene disruption requires LOH (loss of heterozygosity)- requires both alleles for loss of function (c.f. oncogenic activation)
Many tumour suppressor genes regulate cell cycle progression
S: unreplicated or damaged DNA
G2/M: unreplicated or damaged DNA
M: chromosome misalignment
G1/s: damaged DNA
Tumour suppressors: Rb
Retinoblastoma originally defined as a gene associated with the development of an inherited eye tumour
Bi-allelic Rb loss directly leads to retinoblastoma
Most common paediatric eye cancer
1:200,000 births
Accounts for 3% of cancers in children under 15 years
Rb: MOA
Rb1 encodes 928aa protein that regulates E2F function
Proto-oncogenes
Proto-oncogenes are normal genes that have the propensity to support cancer when mutated
Whereas tumour suppressor gene mutation is recessive, oncogenic mutation is dominant
Oncogenes by location
Secreted Membrane associated Transmembrane Cytosolic Nuclear
Oncogenes by function
Growth factors Growth factor receptors G proteins Intracellular kinases TxFs
Mechanisms of proto-oncogene conversion
Chromosomal rearrangements (translocation and inversion) Amplification Point mutations
erbB2 oncogenic amplification
Member of erbB (EGFR) family
Her2 overexpression/activation characterizes specific cancers e.g. breast, gastric, ovarian